Haematological Parameters in Chronic Kidney Disease

Main Article Content

Husna Dilshana. K
Manjunath GV

Abstract

Chronic Kidney disease is a condition where gradual decline of renal function can happen with time, leading to end-stage renal disease. The early detection becomes relevant to avoid the progression .and this study aimed to analyse the hematological parameters in CKD stages 3, 4 and 5 with a comparative evaluation of those that do not require hemodialysis and those managed by hemodialysis.


A 2ml EDTA blood sample of the patient was analyzed in an automated 6-part analyzer with peripheral smear prepared. eGFR was calculated with CKD-EPI formula with patients categorized into stages 3,4 and 5, with 26 patients in each. A comparison analysis of hematological parameters was done between stages.


Mean age remained around 60 with most cases having normocytic normochromic anemia Total count increased with neutrophilia with other differential counts within normal range. There is decrease in RBC count and hematocrit with increase in immature granulocytes. Mean corpuscular volume, Mean corpuscular hemoglobin and hemoglobin concentration with retic and Immature reticulocyte fraction remained in normal range with mean reticulocyte hemoglobin equivalent decreased. Mean platelet count remained within normal level with increase in Mean platelet volume and mean Platelet distribution width with progression of stages. As the duration of dialysis increased, total count decreased. Hemoglobin ,RBC count with hematocrit decreased. Red cell indices increased and Platelet count decreased with increase in Mean platelet volume.


Analysing these differences at the earliest will help in better management of CKD and helps to impede the progression from 3 to 5 stages.

Article Details

How to Cite
K, Husna Dilshana., and Manjunath GV. 2025. “Haematological Parameters in Chronic Kidney Disease”. International Journal of Medical Science and Clinical Research Studies 5 (12):2043-48. https://doi.org/10.47191/ijmscrs/v5-i12-17.
Section
Articles

References

I. BEHERA BP. Hematological profile in patients of chronic kidney disease with its severity in a tertiary care hospital, north odisha. Asian J Pharm Clin Res. 2020;13(8):1-6.

II. George S, Pullockara J, Sailesh K, J K M. A study to assess changes in hematological profile in chronic kidney disease. The Pharma Innovation. 2015;4(6):1-3.

III. Bhattacharjee K, Das D, Rabha P, Kalwar A, Kar G, Bhattacharjee P. A study on haematological profile in patients of chronic renal failure with special reference to serum iron profile. Journal of Evidence Based Medicine and Healthcare. 2015;2(46):8212-8219.

IV. Dewan P, Patil N, Bharti M. Hematological Profile In Cases Of Chronic Renal Diseases. IOSR Journal of Dental and Medical Sciences. 2017;16(04):01-03.

V. George C, Matsha T, Erasmus R, Kengne A. Haematological profile of chronic kidney disease in a mixed-ancestry South African population: a cross-sectional study. BMJ Open. 2018;8(11):1-9.

VI. Afshar R, Sanavi S, Salimi J, Ahmadzadeh M. Hematological profile of chronic kidney disease (CKD) patients in Iran, in pre-dialysis stages and after initiation of hemodialysis. Saudi Journal of Kidney Diseases and Transplantation. 2010 Mar 1;21(2):368.

VII. Talwar VK, Gupta HL, Narayan S. Clinico haematological profile in chronic renal failure. J Assoc Physicians India 2002;50:228‑ 33.

VIII. Islam MN, Ferdous A, Zahid AZ, Alam M, Islam MN. Haematological profile of patients with chronic kidney disease in Northern Bangladesh. Dinajpur Med Col J. 2015 Jan;8(1):1-7.

IX. Hasibuan H, Nasution S, Tarigan R. Correlation of reticulocyte hemoglobin equivalent (ret-HE) levels and iron deficiency anemia in CKD patients treating regular hemodialysis. International Journal of Research and Review. 2021;8(11):10–6.

X. Ju HY, Kim JK, Hur SM, Woo SA, Park KA, Park MY, Choi SJ, Hwang SD. Could mean platelet volume be a promising biomarker of progression of chronic kidney disease?. Platelets. 2015 Feb 17;26(2):143-7.

XI. Lokesh S, Green SR, Mathew TK, Hemachandar R, Kumar A, Tiwari SR, Lakshmi A, Ezhumalai G. A comparative study of platelet parameters in end stage renal disease patients undergoing haemodialysis and healthy individuals. Int J Adv Med. 2016 Aug;3(3):559-63.

XII. Mohammad DK. Effect of Hemodialysis and peritoneal dialysis on some hematological and biochemical parameters in renal failure. Zanco Journal of Medical Sciences (Zanco J Med Sci). 2009;13(2):79-85.

XIII. Toki Y, Ikuta K, Kawahara Y, Niizeki N, Kon M, Enomoto M, Tada Y, Hatayama M, Yamamoto M, Ito S, Shindo M. Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency. International journal of hematology. 2017 Jul;106(1):116-25.

XIV. Bat T, Bat BE, El‐Moghraby A, Patel S, Feng X, Dunbar CE, Sarac E. Thrombopoietic status of patients on haemodialysis. British journal of haematology. 2016 Mar;172(6):954-7.

XV. Aziz AF, Saad AT, Bazeed MM, Allam MA, Bakeer MS. A comparative study of platelet parameters in chronic kidney disease, end stage renal disease patients undergoing hemodialysis and healthy individuals. The Egyptian Journal of Hospital Medicine. 2018 Apr 1;71(6):3429-33.

XVI. Tunca O, Kazan S, Kazan ED. Can mean platelet volume predicts renal outcome in acute on chronic kidney disease? Therapeutic Apheresis and Dialysis. 2022 Sep 27:1-8.